Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana

Record History

See every version on ClinicalTrials.gov ↗

1. Notable May 26, 2026 Results first posted: May 27, 2026v9 Show 5 more changesShow less

   • Primary endpoint revised
   • Enrollment target: 2000 to 1995
   • Secondary endpoints revised (2)
   • Site details revised
   • Study arms: 1 to 2
2. Minor Feb 5, 2014 Trial status: Active, Not Recruiting to Completed

   • Study completion date changed from estimate of Jul 2013 to May 2011
   • Publications: 7 to 10

   v8
3. Minor Sep 26, 2012 Study completion date: Jul 2011 to Jul 2013v7
4. Notable Mar 30, 2011 Primary endpoint revisedv6 Show 8 more changesShow less

   • Primary completion date: Jul 2009
   • Study completion date: Jul 2011
   • Interventions: Continued vs. Limited isoniazid preventive therapy (Drug) to Isoniazid (Drug)
   • Secondary endpoints: 3 to 2
   • Study site revised
   • Publications: 4 to 7
   • Study arms: 0 to 1
   • Study description expanded, about 1 word
5. Minor Dec 10, 2008 Enrollment target: 1800 to 2000

   • Study description shortened, about 12 words
   • Eligibility criteria expanded, about 1 word

   v5

9. Sep 9, 2005 Study First Submitted

• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.